This is our "HOLY GRAIL " moment! If NEO is as good or better than Car-T therapy we have a slam dunk with less side effects and HOT still in the wings... if Amgen doesn't step up and buy us out it could be a better deal for us if HOT does better than NEO. Chess game is being played and if Amgen is trying to low ball us and NEO shows great results it could end up biting Amgen in the buttocks. Hot would then command a great price since NEO would work great with our platform , only makes since HOT would as well! This could get crazy down the road. Trust me I would rather sell shares now to dilute rather than give away the company for "BEAN"
News 
Market Data 
Discover 
AI
